Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.

The Oncology Institute, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

CERRITOS, CALIF., JULY 27, 2026 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (TOI) (NASDAQ: TOI) A PIONEER IN VALUE-BASED COMMUNITY ONCOLOGY CARE, TODAY ANNOUNCED THAT THE COMPANY WILL RELEASE ITS SECOND QUARTER 2026 FINANCIAL RESULTS ON THURSDAY, AUGUST 6, 2026, TO BE FOLLOWED BY A CONFERENCE CALL THE SAME DAY AT 5:00 P.M.

THE ONCOLOGY INSTITUTE ANNOUNCES SECOND QUARTER 2026 EARNINGS RELEASE DATE AND CONFERENCE CALL

CERRITOS, CALIF., JULY 07, 2026 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. ("TOI") (NASDAQ: TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, ANNOUNCED TODAY THAT IT HAS REPAID ITS $86 MILLION SENIOR SECURED CONVERTIBLE NOTE WITH DEERFIELD PARTNERS THROUGH A DEBT REFINANCING THAT INCLUDES NEW CREDIT FACILITIES FROM ORBIMED.

THE ONCOLOGY INSTITUTE COMPLETES STRATEGIC REFINANCING WITH ORBIMED, REPAYING THE OUTSTANDING $86 MILLION DEERFIELD CONVERTIBLE NOTE, STRENGTHENING ITS BALANCE SHEET, AND IMPROVING LIQUIDITY

TORONTO, MAY 31, 2026 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TSXV: TOI), ACTING THROUGH ITS SUBSIDIARY TSS EUROPE B.V. (TSS), TODAY SUBMITTED A REVISED NON-BINDING INDICATIVE PROPOSAL TO ACQUIRE READYTECH HOLDINGS LIMITED (ASX: RDY) (READYTECH) BY WAY OF A SCHEME OF ARRANGEMENT FOR CASH CONSIDERATION OF$2.00 PER SHARE (THE SCHEME CONSIDERATION), OR IN THE ALTERNATIVE, AN OFF-MARKET TAKEOVER BID WITH A 50.1% MINIMUM ACCEPTANCE CONDITION AT A CASH CONSIDERATION OF $1.75 PER SHARE (THE "TAKEOVER CONSIDERATION") (TOGETHER, THE "REVISED PROPOSAL")1. ALL REFERENCES HEREIN TO CURRENCY ARE IN AUSTRALIAN DOLLARS.

TOPICUS.COM INC. ANNOUNCES A REVISED PROPOSAL TO ACQUIRE READYTECH

CERRITOS, CALIF., MAY 26, 2026 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (TOI) (NASDAQ: TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, TODAY ANNOUNCED THAT YALE D.

THE ONCOLOGY INSTITUTE CHIEF MEDICAL OFFICER TO SPEAK ON VALUE-BASED SPECIALTY CARE AT APG SPRING CONFERENCE

CERRITOS, CALIF., MAY 13, 2026 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI), ONE OF THE LARGEST VALUE-BASED ONCOLOGY GROUPS IN THE UNITED STATES, TODAY ANNOUNCED THAT DR. DANIEL VIRNICH, CHIEF EXECUTIVE OFFICER, AND ROB CARTER, CHIEF FINANCIAL OFFICER, WILL PARTICIPATE IN THE B.

THE ONCOLOGY INSTITUTE TO PARTICIPATE IN B. RILEY SECURITIES INSTITUTIONAL INVESTOR CONFERENCE

TORONTO, MAY 11, 2026 (GLOBE NEWSWIRE) -- AS PREVIOUSLY ANNOUNCED ON APRIL 10, 2026, THE TOPICUS.COM INC. (TOPICUS) (TSXV:TOI) ANNUAL GENERAL MEETING OF SHAREHOLDERS WILL BE HELD ON FRIDAY, MAY 15, 2026 AT 8:00 A.M. ET USING A HYBRID MEETING FORMAT WITH PROCEEDINGS CONDUCTED VIA LIVE WEBCAST AND IN PERSON. THE LUMINE GROUP INC. (LUMINE GROUP) (TSXV:LMN) ANNUAL GENERAL MEETING OF SHAREHOLDERS WILL BE HELD ON FRIDAY, MAY 15, 2026 AT 8:15 A.M. ET USING A HYBRID MEETING FORMAT WITH PROCEEDINGS CONDUCTED VIA LIVE WEBCAST AND IN PERSON. THE CONSTELLATION SOFTWARE INC. (CONSTELLATION OR CSI) (TSX:CSU) ANNUAL MEETING OF SHAREHOLDERS WILL BE HELD ON FRIDAY, MAY 15, 2026 AT 8:30 A.M. ET USING A HYBRID MEETING FORMAT WITH PROCEEDINGS CONDUCTED VIA LIVE WEBCAST AND IN PERSON. THE TOPICUS MEETING, LUMINE MEETING, AND CONSTELLATION MEETING WILL TAKE PLACE IN PERSON AT DELTA HOTELS TORONTO, 75 LOWER SIMCOE STREET, TORONTO, ONTARIO, M5J 3A6.

CONSTELLATION SOFTWARE INC., TOPICUS.COM INC. AND LUMINE GROUP INC. ANNOUNCE UPDATE TO SCHEDULE FOR ANNUAL MEETINGS

CERRITOS, CALIF., MAY 07, 2026 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (NASDAQ: TOI) (TOI OR THE COMPANY), ONE OF THE LARGEST VALUE-BASED COMMUNITY ONCOLOGY GROUPS IN THE UNITED STATES, TODAY REPORTED FINANCIAL RESULTS FOR ITS THREE MONTHS ENDED MARCH 31, 2026.

THE ONCOLOGY INSTITUTE REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

TORONTO, MAY 05, 2026 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TSXV:TOI) IN A JOINT RELEASE WITH CONSTELLATION SOFTWARE INC. (TSX:CSU) TODAY ANNOUNCED FINANCIAL RESULTS FOR TOPICUS.COM INC. (TOPICUS OR THE COMPANY) FOR THE FIRST QUARTER ENDED MARCH 31, 2026. PLEASE NOTE THAT ALL AMOUNTS REFERRED TO IN THIS PRESS RELEASE ARE IN EUROS UNLESS OTHERWISE STATED.

CONSTELLATION SOFTWARE INC. AND TOPICUS.COM INC. ANNOUNCE RESULTS FOR TOPICUS.COM INC. FOR THE FIRST QUARTER ENDED MARCH 31, 2026

CERRITOS, CALIF., APRIL 27, 2026 (GLOBE NEWSWIRE) -- THE ONCOLOGY INSTITUTE, INC. (TOI) (NASDAQ: TOI) A PIONEER IN VALUE-BASED COMMUNITY ONCOLOGY CARE, TODAY ANNOUNCED THAT THE COMPANY WILL RELEASE ITS FIRST QUARTER 2026 FINANCIAL RESULTS ON THURSDAY, MAY 7, 2026, TO BE FOLLOWED BY A CONFERENCE CALL THE SAME DAY AT 5:30 P.M.

THE ONCOLOGY INSTITUTE ANNOUNCES FIRST QUARTER 2026 EARNINGS RELEASE DATE AND CONFERENCE CALL

TORONTO, APRIL 15, 2026 (GLOBE NEWSWIRE) -- TOPICUS.COM INC. (TSXV:TOI) ANNOUNCED TODAY IT INTENDS TO RELEASE ITS FIRST QUARTER RESULTS ONMAY 5, 2026.

The Oncology Institute, Inc.

TOI

Price

Financial Reports

No items found.

Press Releases

The Oncology Institute, Inc.

TOI.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

TOI